We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+13.1%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$1.08T
AUM Growth
+$125B
Cap. Flow
+$32.6B
Cap. Flow %
3.01%
Top 10 Hldgs %
27.52%
Holding
4,738
New
85
Increased
3,720
Reduced
276
Closed
123

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.81B
2
MSFT icon
Microsoft
MSFT
+$1.34B
3
AAPL icon
Apple
AAPL
+$1.25B
4
AMZN icon
Amazon
AMZN
+$1.17B
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$480M

Sector Composition

Rank Sector Weight
1 Technology 29.47%
2 Financials 12.91%
3 Healthcare 12.22%
4 Consumer Discretionary 10.6%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABVC icon
4426
ABVC BioPharma
ABVC
$26.5M
$28.8K ﹤0.01%
22,000
+2,520
+13% +$3.27K
CAUD
4427
DELISTED
Collective Audience, Inc.. Common Stock
CAUD
$28.8K ﹤0.01%
46,026
+6,940
+18% +$6.73K
CLLS
4428
Cellectis
CLLS
$279M
$28.6K ﹤0.01%
10,776
FUV
4429
DELISTED
Arcimoto, Inc. Common Stock
FUV
$28.4K ﹤0.01%
61,080
+3,933
+7% +$2.44K
MNPR icon
4430
Monopar Therapeutics
MNPR
$798M
$28.1K ﹤0.01%
8,240
GBR icon
4431
New Concept Energy
GBR
$3.4M
$27.8K ﹤0.01%
26,474
BRNS
4432
Barinthus Biotherapeutics
BRNS
$23.3M
$27.8K ﹤0.01%
11,568
UAVS icon
4433
AgEagle Aerial Systems
UAVS
$53.7M
$27.7K ﹤0.01%
703
-3
-0.4% -$208
MIMO
4434
DELISTED
Airspan Networks Holdings Inc
MIMO
$27.2K ﹤0.01%
241,033
MSPR
4435
DELISTED
MSP Recovery Inc
MSPR
$27.1K ﹤0.01%
226
+18
+9% +$3.37K
ACHL
4436
DELISTED
Achilles Therapeutics
ACHL
$27K ﹤0.01%
21,590
IVF
4437
INVO Fertility Inc
IVF
$1.89M
$26.8K ﹤0.01%
17
-2
-11% -$3.05K
HYFT
4438
MindWalk Holdings
HYFT
$60.1M
$26.6K ﹤0.01%
17,484
SUNE
4439
SUNation Energy
SUNE
$11.5M
$26.5K ﹤0.01%
+3
New +$112K
ENSV
4440
DELISTED
Enservco Corp.
ENSV
$26.4K ﹤0.01%
136,660
WHLR
4441
Wheeler Real Estate Investment Trust
WHLR
$440K
0
WIMI
4442
WiMi Hologram Cloud
WIMI
$24.5M
$26.3K ﹤0.01%
2,899
KPRX icon
4443
Kiora Pharmaceuticals
KPRX
$11.6M
$26.3K ﹤0.01%
4,135
SELX
4444
DELISTED
Semilux International
SELX
$26.2K ﹤0.01%
+16,572
New +$24.4K
CVKD icon
4445
Cadrenal Therapeutics
CVKD
$7.21M
$26.1K ﹤0.01%
2,858
+275
+11% +$3.49K
ARBK
4446
Argo Blockchain
ARBK
$42.4M
$25.9K ﹤0.01%
55
KA
4447
DELISTED
Kineta, Inc. Common Stock
KA
$25.9K ﹤0.01%
50,031
-553
-1% -$1.1K
MSN icon
4448
Emerson Radio
MSN
$7.71M
$25.3K ﹤0.01%
47,668
OPGN
4449
DELISTED
OpGen, Inc
OPGN
$25.2K ﹤0.01%
3,630
-46
-1% -$202
ABLV icon
4450
Able View Global
ABLV
$38.6M
$25.2K ﹤0.01%
+10,224
New +$28.2K

Similar funds

Geode Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.

  • Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
  • Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
  • Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
  • Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
  • Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
  • Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
  • Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.